| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emergent Biosolutions Inc. (EBS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. EBS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 374.1K | $3.11M | - | |
| CEO | 305.4K | $2.54M | - | |
| VP | 202.2K | $1.68M | - | |
| VP | 185.6K | $1.54M | - | |
| VP | 162.1K | $1.35M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Havey Adam | EVP, Business Operations | Sell | 5,842 | $52.82 | $308,574.44 | -16.3% | |
| Mar 1, 2018 | Havey Adam | EVP, Business Operations | Sell | 1,898 | $49.50 | $93,951.00 | -5.4% | |
| Jan 23, 2018 | Hauer Jerome M | Director | Sale+OE | 7,729 | $50.69 | $391,786.69 | -18.2% | |
| Jan 2, 2018 | Abdun-Nabi Daniel | President &CEO | Sale+OE | 21,906 | $47.91 | $1,049,516.46 | -9.7% | |
| Dec 13, 2017 | Abdun-Nabi Daniel | President &CEO | Sale+OE | 20,000 | $45.99 | $919,800.00 | -8.9% | |
| Dec 12, 2017 | Richard Ronald | Director | Sale+OE | 23,681 | $45.02 | $1,066,225.18 | -50.3% | |
| Dec 7, 2017 | Harsanyi Zsolt | Director | Sell | 7,000 | $42.47 | $297,290.00 | -15.9% | |
| Nov 29, 2017 | El-Hibri Fuad | Chairman | Sale+OE | 47,983 | $41.88 | $2,009,324.64 | -1.5% | |
| Nov 14, 2017 | El-Hibri Fuad | Chairman | Sell | 40,000 | $40.37 | $1,614,800.00 | -1.3% | |
| Nov 8, 2017 | Zoon Kathryn C62 | Director | Sell | 2,742 | $39.20 | $107,490.28 | -6.4% |